Daniel Loeb acquired 385 Thousand Biomarin Pharmaceutical - Registered Shares shares worth $32.3 Million. That's 0.46% of their equity portfolio (25th largest holding). The first Biomarin Pharmaceutical - Registered Shares trade was made in Q4 2007. Since then Daniel Loeb bought shares two more times and sold shares on one occasions. The investor's estimated purchase price is $34.1 Million, resulting in a loss of 5.3%.